Amgen stalls Samsung’s Enbrel biosim until 2029 in 2nd patent win of the year
By Fraiser Kansteiner Amgen’s update marks the second setback for an Enbrel biosimilar this year. (Amgen) Amgen breathed a sigh
Read MoreBy Fraiser Kansteiner Amgen’s update marks the second setback for an Enbrel biosimilar this year. (Amgen) Amgen breathed a sigh
Read MoreBy Blake Brittain 2 minute read Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration
Read MoreChina’s National Intellectual Property Administration Releases Report on 2021 Patent Agency Industry – China has 60,369 Patent Agents; 47,511 Registered
Read MoreThe European Union agency responsible for the trademark has accepted a request from Turkey for the registration of the term
Read MoreJune 22, 2022 The European Patent Office (EPO) today honored MIT chemistry professor Donald Sadoway with the 2022 European Inventor
Read More